BALPHARMAPharmaceuticals
Bal Pharma Ltd — Quarterly Results & Earnings
₹60.42
-1.51%
Profit Growth YoY-31.73%Latest quarter
Sales Growth YoY0.45%Latest quarter
Sales CAGR 5Y12.11%5 year compound
Profit CAGR 5Y20.95%5 year compound
📋
Quarterly Performance
YoY Profit Growth-31.73%
🔴 Significant decline
YoY Sales Growth+0.45%
📈 Moderate growth
OPM 5Y Average
9.10%Operating profit margin
EPS Growth 5Y
20.34%Interest Coverage
1.24Higher = safer debt servicing
ROE
9.66%ROCE
10.10%💡
Growth Analysis
Bal Pharma Ltd reported YoY profit growth of -31.73% and revenue growth of 0.45% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 12.11% and profits at 20.95% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Bal Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.